Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of AVT Discontinuation in HBV Pregnant Women
NCT03468907Phase 4Completed
- Sponsor
- The Third Affiliated Hospital of Sun Yat-sen University
- Start
- Jun 2015
- Primary completion
- Dec 2017
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
A Phase 4 trial of telbivudine, tenofovir disoproxil fumarate in Chronic Hepatitis B (CHB), sponsored by The Third Affiliated Hospital of Sun Yat-sen University. Started Jun 2015; status: completed.
02
Drugs
telbivudinetenofovir disoproxil fumarate
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT03468907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03468907.